Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P53350 |
PLK1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 |
PLK1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 |
PLK1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P53350 |
PLK1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 |
PLK1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P53350 |
PLK1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P53350 |
PLK1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q03431 |
PTH1R_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q03431 |
PTH1R_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
P25779 |
CYSP_TRYCR |
Parasitic worm infestation [ICD-11: 1F90] |
P25779 |
CYSP_TRYCR |
Malaria [ICD-11: 1F40-1F45] |
P01375 |
TNFA_HUMAN |
Crohn disease [ICD-11: DD70] |
P01375 |
TNFA_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P01375 |
TNFA_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P01375 |
TNFA_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P01375 |
TNFA_HUMAN |
Asthma [ICD-11: CA23] |
P01375 |
TNFA_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P01375 |
TNFA_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P01375 |
TNFA_HUMAN |
Pancreatitis [ICD-11: DC31-DC34] |
P01375 |
TNFA_HUMAN |
Pemphigus [ICD-11: EB40] |
P01375 |
TNFA_HUMAN |
Psoriasis [ICD-11: EA90] |
P01375 |
TNFA_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P01375 |
TNFA_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
P01375 |
TNFA_HUMAN |
Spinal pain [ICD-11: ME84] |
P01375 |
TNFA_HUMAN |
Cystic fibrosis [ICD-11: CA25] |
P01375 |
TNFA_HUMAN |
Esophageal cancer [ICD-11: 2B70] |
P01375 |
TNFA_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P01375 |
TNFA_HUMAN |
Systemic sclerosis [ICD-11: 4A42] |
P01375 |
TNFA_HUMAN |
Atopic eczema [ICD-11: EA80] |
P01375 |
TNFA_HUMAN |
Bowel habit change [ICD-11: ME05] |
P01375 |
TNFA_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P01375 |
TNFA_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
P01375 |
TNFA_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P01375 |
TNFA_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P01375 |
TNFA_HUMAN |
Pneumonia [ICD-11: CA40] |
P01375 |
TNFA_HUMAN |
Psoriatic arthritis [ICD-11: FA21] |
P01375 |
TNFA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P01375 |
TNFA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P01375 |
TNFA_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
P01375 |
TNFA_HUMAN |
Crohn disease [ICD-11: DD70] |
P01375 |
TNFA_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P01375 |
TNFA_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
P01375 |
TNFA_HUMAN |
Infectious gastroenteritis/colitis [ICD-11: 1A40] |
Q9HC29 |
NOD2_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
Q9HC29 |
NOD2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q9HC29 |
NOD2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |